Back to results
US 2023/0398108 A1Published application
Pharmaceutical Compositions of a Kinase Inhibitor
AssigneeExelixis, lnc.
InventorsIswadi LIEJANTO, Tzu-Yuan CHEN
Life of this patent
Estimating the term…
Abstract
The present invention relates to pharmaceutical compositions of the c-Met inhibitor, Compound 1. The invention also relates to methods of treating a disease, disorder, or syndrome mediated at least in part by modulating in vivo activity of a protein kinase using the pharmaceutical composition and to processes for making the pharmaceutical compositions.
Claims32
A pharmaceutical composition suitable for oral administration, comprising:
- a. Compound 1, which has the structure:
- or a pharmaceutically acceptable salt thereof;
- b. one or more diluents;
- c. one or more binders;
- d. one or more disintegrants;
- e. one or more glidants;
- f. one or more lubricants;
- and optionally
- g. a film coating.
6 more elements
Dependencies are inferred from the claim text.